BIOMAT Database Logo BIOMAT Database Logo

Genome-wide DNA Methylation Profiling Reveals Methylation Markers Associated with 3q Gain for Detection of Cervical Precancer and Cancer. 2017

Wina Verlaat, and Peter J F Snijders, and Putri W Novianti, and Saskia M Wilting, and Lise M A De Strooper, and Geert Trooskens, and Johan Vandersmissen, and Wim Van Criekinge, and G Bea A Wisman, and Chris J L M Meijer, and Daniëlle A M Heideman, and Renske D M Steenbergen
Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands.

Purpose: Epigenetic host cell changes involved in cervical cancer development following a persistent high-risk human papillomavirus (hrHPV) infection, provide promising markers for the management of hrHPV-positive women. In particular, markers based on DNA methylation of tumor suppressor gene promoters are valuable. These markers ideally identify hrHPV-positive women with precancer (CIN2/3) in need of treatment. Here, we set out to identify biologically relevant methylation markers by genome-wide methylation analysis of both hrHPV-transformed cell lines and cervical tissue specimens.Experimental Design and Results: Genome-wide discovery by next-generation sequencing (NGS) of methyl-binding domain-enriched DNA (MBD-Seq) yielded 20 candidate methylation target genes. Further verification and validation by multiplex-targeted bisulfite NGS and (quantitative) methylation-specific PCR (MSP) resulted in 3 genes (GHSR, SST, and ZIC1) that showed a significant increase in methylation with severity of disease in both tissue specimens and cervical scrapes (P < 0.005). The area under the ROC curve for CIN3 or worse varied between 0.86 and 0.89. Within the group of CIN2/3, methylation levels of all 3 genes increased with duration of lesion existence (P < 0.0005), characterized by duration of preceding hrHPV infection, and were significantly higher in the presence of a 3q gain (P < 0.05) in the corresponding tissue biopsy.Conclusions: By unbiased genome-wide DNA methylation profiling and comprehensive stepwise verification and validation studies using in vitro and patient-derived samples, we identified 3 promising methylation markers (GHSR, SST, and ZIC1) associated with a 3q gain for the detection of cervical (pre)cancer. Clin Cancer Res; 23(14); 3813-22. ©2017 AACR.

UI MeSH Term Description Entries
D011230 Precancerous Conditions Pathological conditions that tend eventually to become malignant. Preneoplastic Conditions,Condition, Preneoplastic,Conditions, Preneoplastic,Preneoplastic Condition,Condition, Precancerous,Conditions, Precancerous,Precancerous Condition
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D002893 Chromosomes, Human, Pair 3 A specific pair of human chromosomes in group A (CHROMOSOMES, HUMAN, 1-3) of the human chromosome classification. Chromosome 3
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013004 Somatostatin A 14-amino acid peptide named for its ability to inhibit pituitary GROWTH HORMONE release, also called somatotropin release-inhibiting factor. It is expressed in the central and peripheral nervous systems, the gut, and other organs. SRIF can also inhibit the release of THYROID-STIMULATING HORMONE; PROLACTIN; INSULIN; and GLUCAGON besides acting as a neurotransmitter and neuromodulator. In a number of species including humans, there is an additional form of somatostatin, SRIF-28 with a 14-amino acid extension at the N-terminal. Cyclic Somatostatin,Somatostatin-14,Somatotropin Release-Inhibiting Hormone,SRIH-14,Somatofalk,Somatostatin, Cyclic,Somatotropin Release-Inhibiting Factor,Stilamin,Somatostatin 14,Somatotropin Release Inhibiting Factor,Somatotropin Release Inhibiting Hormone
D014157 Transcription Factors Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process. Transcription Factor,Factor, Transcription,Factors, Transcription
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers
D015894 Genome, Human The complete genetic complement contained in the DNA of a set of CHROMOSOMES in a HUMAN. The length of the human genome is about 3 billion base pairs. Human Genome,Genomes, Human,Human Genomes
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Wina Verlaat, and Peter J F Snijders, and Putri W Novianti, and Saskia M Wilting, and Lise M A De Strooper, and Geert Trooskens, and Johan Vandersmissen, and Wim Van Criekinge, and G Bea A Wisman, and Chris J L M Meijer, and Daniëlle A M Heideman, and Renske D M Steenbergen
Evaluation of six methylation markers derived from genome-wide screens for detection of cervical precancer and cancer.
September 2020, Epigenomics,
Wina Verlaat, and Peter J F Snijders, and Putri W Novianti, and Saskia M Wilting, and Lise M A De Strooper, and Geert Trooskens, and Johan Vandersmissen, and Wim Van Criekinge, and G Bea A Wisman, and Chris J L M Meijer, and Daniëlle A M Heideman, and Renske D M Steenbergen
Genome-wide DNA methylation profiling reveals cancer-associated changes within early colonic neoplasia.
August 2017, Oncogene,
Wina Verlaat, and Peter J F Snijders, and Putri W Novianti, and Saskia M Wilting, and Lise M A De Strooper, and Geert Trooskens, and Johan Vandersmissen, and Wim Van Criekinge, and G Bea A Wisman, and Chris J L M Meijer, and Daniëlle A M Heideman, and Renske D M Steenbergen
Genome-wide DNA methylation profiling reveals parity-associated hypermethylation of FOXA1.
October 2014, Breast cancer research and treatment,
Wina Verlaat, and Peter J F Snijders, and Putri W Novianti, and Saskia M Wilting, and Lise M A De Strooper, and Geert Trooskens, and Johan Vandersmissen, and Wim Van Criekinge, and G Bea A Wisman, and Chris J L M Meijer, and Daniëlle A M Heideman, and Renske D M Steenbergen
Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancer.
August 2017, International journal of cancer,
Wina Verlaat, and Peter J F Snijders, and Putri W Novianti, and Saskia M Wilting, and Lise M A De Strooper, and Geert Trooskens, and Johan Vandersmissen, and Wim Van Criekinge, and G Bea A Wisman, and Chris J L M Meijer, and Daniëlle A M Heideman, and Renske D M Steenbergen
Validation of novel DNA methylation markers in cervical precancer and cancer.
January 2024, International journal of cancer,
Wina Verlaat, and Peter J F Snijders, and Putri W Novianti, and Saskia M Wilting, and Lise M A De Strooper, and Geert Trooskens, and Johan Vandersmissen, and Wim Van Criekinge, and G Bea A Wisman, and Chris J L M Meijer, and Daniëlle A M Heideman, and Renske D M Steenbergen
Genome-wide DNA methylation profiling in whole blood reveals epigenetic signatures associated with migraine.
January 2018, BMC genomics,
Wina Verlaat, and Peter J F Snijders, and Putri W Novianti, and Saskia M Wilting, and Lise M A De Strooper, and Geert Trooskens, and Johan Vandersmissen, and Wim Van Criekinge, and G Bea A Wisman, and Chris J L M Meijer, and Daniëlle A M Heideman, and Renske D M Steenbergen
Profiling genome-wide DNA methylation.
January 2016, Epigenetics & chromatin,
Wina Verlaat, and Peter J F Snijders, and Putri W Novianti, and Saskia M Wilting, and Lise M A De Strooper, and Geert Trooskens, and Johan Vandersmissen, and Wim Van Criekinge, and G Bea A Wisman, and Chris J L M Meijer, and Daniëlle A M Heideman, and Renske D M Steenbergen
Genome-wide DNA methylation profiling.
January 2010, Wiley interdisciplinary reviews. Systems biology and medicine,
Wina Verlaat, and Peter J F Snijders, and Putri W Novianti, and Saskia M Wilting, and Lise M A De Strooper, and Geert Trooskens, and Johan Vandersmissen, and Wim Van Criekinge, and G Bea A Wisman, and Chris J L M Meijer, and Daniëlle A M Heideman, and Renske D M Steenbergen
Genome-wide profiling of DNA methylation reveals transposon targets of CHROMOMETHYLASE3.
January 2002, Current biology : CB,
Wina Verlaat, and Peter J F Snijders, and Putri W Novianti, and Saskia M Wilting, and Lise M A De Strooper, and Geert Trooskens, and Johan Vandersmissen, and Wim Van Criekinge, and G Bea A Wisman, and Chris J L M Meijer, and Daniëlle A M Heideman, and Renske D M Steenbergen
Emerging technologies for genome-wide DNA methylation profiling in cancer.
December 2006, Critical reviews in oncogenesis,
Copied contents to your clipboard!